We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BIO: FDA Drug Approval Rate Lower Than Previously Reported
BIO: FDA Drug Approval Rate Lower Than Previously Reported
February 18, 2011
A new study using data from the Biotechnology Industry Organization’s (BIO’s) BioMedTracker (BMT) proprietary database suggests that only one in 10 drugs wending their way through the clinical pipeline ever receives FDA approval.